CoChat

3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab

Open access
Li, Yang, Zhang, Ting, Pang, Yuan, Li, Ling, Chen, Zhi-Nan, Sun, Wei · 2019 · Biofabrication
Cited by 59

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Constructing in vitro drug models with a higher degree of bionics is considered to be an important approach to improve the effectiveness of existing drug screening models. 3D printing, co-culture and microfluidics are important methods that commonly used. This study combined the advantages of the three methods. A 3D co-culture microfluidic model with controllable hepatoma cluster size was constructed, and applied to pharmacodynamic tests of a new anti-CD147 monoclonal antibody, Metuzumab. In the phase of cell preparation, hepatoma cells in the new model were found to proliferate faster than common in vitro 3D models fabricated by cell printing only. The hepatoma cells were also found less affected by the increase of drug dosage in migration performance, proliferation performance and protein expression level in the new model compared with 2D models. These results are in line with those obtained from animal experiments and clinical trials of similar anti-CD147 antibody drugs. In view of the special mechanism of antibody drugs, a modified model was built by adding peripheral blood mononuclear cells into the new model as effector cells, porting traditional antibody-dependent cell-mediated cytotoxicity (ADCC) test to a co-culture 3D microfluidic microenvironment. The results showed that ADCC exhibited higher effectiveness in the microfluidic model than in 3D printing models under the same dose of drug treatment. The new model was proved constructive and it provided a valuable reference for complex in vitro hepatoma model studies and antibody drug screening researches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1088/1758-5090/ab256c

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 59

Metadata

Authors
Li, Y., Zhang, T., Pang, Y., Li, L., Chen, Z.-N., & Sun, W.
Venue
Biofabrication
Published
2019-06-26
Volume
11
Issue
3
Pages
034102
ISSN
  • 1758-5082 (ISSN-L)
  • 1758-5090
OpenAlex
W2947280116
Cited by
59
References
8
FWCI
2.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab. https://app.cochat.ai/papers/10.1088/1758-5090/ab256c
The paper
Li, Y., Zhang, T., Pang, Y., Li, L., Chen, Z.-N., & Sun, W. (2019). 3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab. Biofabrication. https://doi.org/10.1088/1758-5090/ab256c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.